Bénédicte Daydé-Cazals

Axl Kinase as a Key Target for Oncology: Focus on Small Molecule Inhibitors

G. Chevé, A. Yasri, Clémence Feneyrolles, 2014, Molecular Cancer Therapeutics.

De novo design, synthesis and pharmacological evaluation of new azaindole derivatives as dual inhibitors of Abl and Src kinases

G. Chevé, A. Yasri, O. Loget, 2012 .

Anti-tumor Activity of Novel Compounds Targeting BCR-ABL, c-SRC and BCR-ABLT315I in Chronic Myelogenous Leukemia

P. Auberger, M. Coisy-Quivy, G. Chevé, 2013 .

Anti-tumor Activity of Novel Compounds Targeting BCR-ABL, c-SRC and BCR-ABL in Chronic Myelogenous Leukemia

Patrick, M. Coisy-Quivy, A. Yasri, 2013 .

Build-To-Specification Vanillin and Phloroglucinol Derived Biobased Epoxy-Amine Vitrimers

I. Azcune, A. Genua, A. Graillot, 2020, Polymers.

Rational Design, Synthesis, and Biological Evaluation of 7-Azaindole Derivatives as Potent Focused Multi-Targeted Kinase Inhibitors.

A. Yasri, G. Chevé, F. Gassiot, 2016, Journal of medicinal chemistry.

Recent progress in the design, study, and development of c-Jun N-terminal kinase inhibitors as anticancer agents.

G. Chevé, A. Yasri, K. Bougrin, 2014, Chemistry & biology.

Discovering novel 7-azaindole-based series as potent AXL kinase inhibitors.

A. Yasri, G. Chevé, Clémence Feneyrolles, 2017, Bioorganic & medicinal chemistry letters.